Four Application Scenarios
Milestones
Baiquan Health was formally established. Dropped gene / inflammation / protein testing paths in favor of element detection; Academician Lu confirmed the optical-technology route, and Dr. Wang Jingjing joined the team.
BC408H prototype completed; Class II medical device registration process initiated.
BC408H passed review and obtained the Class II medical device certificate ("Portable Skin Trace Element Monitor") and manufacturing license.
Clinical research concluded; Lianbao Health was formally registered, opening a new commercialization stage.
Anti-drug rapid-screening model achieved breakthrough. Partnered with Beijing Hangxing Technology (China Aerospace's subsidiary): patent licensing + core component supply for co-built custom products; cross-population/region generalization modeling, and ten-thousand-scale dataset accumulation with multiple police bureaus.
Partners
Collaborating with nearly 100 industry partners to build a new digital health ecosystem
Media Coverage
Authoritative media coverage and reports
